Linhao Xu

机构：Hangzhou First People's Hospital · ORCID：0000-0003-1275-665X

发表论文 64 篇 · 总被引 1460 次 · h-index 24

代表论文

Tanshinone IIA inhibits cardiomyocyte apoptosis and rescues cardiac function during doxorubicin-induced cardiotoxicity by activating the DAXX/MEK/ERK1/2 pathway (2022 · Phytomedicine · 被引 71)
Suppression of CHOP Reduces Neuronal Apoptosis and Rescues Cognitive Impairment Induced by Intermittent Hypoxia by Inhibiting Bax and Bak Activation (2021 · Neural Plasticity · 被引 41)
Pharmacological intervention of curcumin via the NLRP3 inflammasome in ischemic stroke (2023 · Frontiers in Pharmacology · 被引 38)
Natural products from traditional Chinese medicine for the prevention and treatment of heart failure: progress and perspectives (2022 · Reviews in Cardiovascular Medicine · 被引 38)
TNFSF14/LIGHT promotes cardiac fibrosis and atrial fibrillation vulnerability via PI3Kγ/SGK1 pathway-dependent M2 macrophage polarisation (2023 · Journal of Translational Medicine · 被引 36)
Activation of SIRT3 by Tanshinone IIA ameliorates renal fibrosis by suppressing the TGF-β/TSP-1 pathway and attenuating oxidative stress (2024 · Cellular Signalling · 被引 19)